- Home
- IRTC
as of 12-15-2025 10:08am EST
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Francisco |
| Market Cap: | 5.8B | IPO Year: | 2016 |
| Target Price: | $203.93 | AVG Volume (30 days): | 479.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $84.17 - $212.00 | Next Earning Date: | 10-30-2025 |
| Revenue: | $702,573,000 | Revenue Growth: | 25.45% |
| Revenue Growth (this year): | 27.2% | Revenue Growth (next year): | 16.89% |
AI-Powered IRTC Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)
CHIEF COMM & PRODUCT OFFICER
Avg Cost/Share
$184.83
Shares
280
Total Value
$51,752.40
Owned After
43,387
SEC Form 4
CBO and CLO
Avg Cost/Share
$184.83
Shares
2,478
Total Value
$458,008.74
Owned After
53,281
SEC Form 4
Director
Avg Cost/Share
$174.71
Shares
5,312
Total Value
$924,961.65
Owned After
22,325
President and CEO
Avg Cost/Share
$182.94
Shares
14,059
Total Value
$2,571,907.07
Owned After
164,979
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$207.44
Shares
8,000
Total Value
$1,659,520.00
Owned After
26,470
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Patterson Chad | IRTC | CHIEF COMM & PRODUCT OFFICER | Dec 2, 2025 | Sell | $184.83 | 280 | $51,752.40 | 43,387 | |
| Murphy Patrick Michael | IRTC | CBO and CLO | Dec 2, 2025 | Sell | $184.83 | 2,478 | $458,008.74 | 53,281 | |
| TALWALKAR ABHIJIT Y | IRTC | Director | Nov 10, 2025 | Sell | $174.71 | 5,312 | $924,961.65 | 22,325 | |
| Blackford Quentin S. | IRTC | President and CEO | Nov 3, 2025 | Sell | $182.94 | 14,059 | $2,571,907.07 | 164,979 | |
| Wilson Daniel G. | IRTC | Chief Financial Officer | Oct 31, 2025 | Sell | $207.44 | 8,000 | $1,659,520.00 | 26,470 |
Compare IRTC vs Leading Stocks
See how IRTC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.